A best evidence topic in cardiothoracic surgery was written according to a structured protocol. The question addressed was whether, in patients undergoing cardiac surgery, concomitant bipolar radiofrequency ablation had an acceptable success rate to justify the additional procedure. Altogether 263 papers were found using the reported search, of which 12 represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. The consensus in the literature was that bipolar radiofrequency ablation was highly successful in restoring sinus rhythm. One meta-analysis of six non-randomized studies demonstrated that 76% of patients were in sinus rhythm compared with 16% in atrial fibrillation 3 months postoperatively. One randomized controlled trial found that the sinus rhythm conversion rate for any maze procedure was highly significant compared with the control group (P = 0.001). Another found that Cardioblate radiofrequency ablation was significantly better at restoring sinus rhythm at 1 year (75 vs 39% control, P = 0.019). Prospective studies showed a similar rate of sinus rhythm return at 1 year (89%). Notably some studies demonstrated a significant reduction in the New York Heart Association class when sinus rhythm was restored compared with those remaining in atrial fibrillation (P < 0.0001), demonstrating the value of this procedure beyond simply restoring sinus rhythm. In another study, the investigators found that both ablation and total procedure times were shorter with bipolar compared with monopolar ablation. These authors strongly recommend bipolar radiofrequency ablation due to a shorter procedure time, ability to avoid performing a standard left atriotomy and a greater guarantee of transmurality. With the current limited evidence, we conclude that bipolar radiofrequency ablation has a higher success rate in restoring sinus rhythm as an adjunct to cardiac surgery compared with no ablation for at least 1 year. The procedure had a high survival rate. There is randomized evidence to suggest the superiority of bipolar radiofrequency ablation over microwave ablation but limited evidence to suggest the superiority of bipolar over unipolar radiofrequency ablation. Factors found to be accurate predictors of ablation failure include a larger preoperative atrial diameter, permanent vs paroxysmal atrial fibrillation and longer duration of atrial fibrillation.
INTRODUCTION
A best evidence topic was constructed according to a structured protocol. This is fully described in the ICVTS [1] .
THREE-PART QUESTION
In [ patients undergoing concomitant cardiac surgery for atrial fibrillation (AF)] is [bipolar radiofrequency ablation (RFA)] compared with [no treatment, catheter-based therapy or other sources of energy] an effective procedure for returning the patient to [sinus rhythm (SR)].
CLINICAL SCENARIO
You have under your care a 57-year old patient with mitral regurgitation and paroxysmal AF. You would like to treat your patient's AF during the procedure. You usually use a bipolar RF device to perform pulmonary vein isolation, but a colleague suggests that RF vein does not have acceptable success rates with regard to SR restoration. You resolve to check from the literature whether or not bipolar ablation is acceptable. studies using only unipolar ablation or other energy modalities [such as microwave (MW) or cryoablation], studies where the ablation technique was ambiguous or not directly specified and papers with highly variable or undisclosed follow-up time. From the search, 12 papers were identified that provided evidence addressing the specific question. These are presented in Table 1 .
RESULTS
Chiappini et al. [2] performed a meta-analysis that identified 6 non-randomized studies that included 451 AF patients undergoing cardiac surgery with concomitant RFA. The overall survival rate was 97.1% with 76% freedom from AF at a mean follow-up period of 13.8 months.
Srivastava et al. [3] and Von Oppell et al. [4] conducted randomized control trials. Srivastava et al. compared biatrial (BAM), left atrial (LAM) and pulmonary vein isolation maze (PVIM) procedures with a control no-maze group. The maze procedures elicited a good success rate (over 50%) of SR maintenance at 6 months. The SR conversion rate for BAM, LAM and PVIM was highly significant compared with the control group (P = 0.001) but there was no significant difference between individual maze procedures. The average extra cross-clamp time required was 5-7 min for maze procedures. Von Oppell et al. [4] compared groups undergoing Cardioblate RF ablation and concomitant surgery vs cardiac surgery alone in patients with persistent or permanent AF. Cardioblate ablation was significantly better at restoring SR at 1 year (75 vs 39%, P = 0.019). An average 30 min extra was required both for bypass and cross-clamp for Cardioblate operations. After performing the first six cases with bipolar only ablation, the authors state that it was difficult to ensure a confluent ablation line between the left pulmonary veins and the mitral valve annulus and the tricuspid valve annulus with the bipolar device alone without potentially injuring coronary arteries. Subsequently, a monopolar pen was used for these lines.
Raman et al. [5] and Benussi et al. [6] both studied the use of Cobra RF ablation on AF patients undergoing concomitant cardiac surgery. Raman studied 132 patients with all forms of AF across 20 centres and found an 84% SR maintenance rate at 3 months (72 of 87), 90% at 6 months (45 of 50) and 100% at 12 months (however, n = 12). These operations required 12-14 min extra cross-clamp time.
Comparatively, Benussi et al. [6] studied 90 patients with AF that was permanent or refractory to anti-arrhythmics and showed 79% maintained in SR at 3 months, 87% at 6 months and 89% at 1 year. Although the success rate appears high, the poor follow-up rates (<50% at 12 months) make conclusions drawn from these success rates potentially unreliable.
Onorati et al. [7] focused on heart failure patients undergoing mitral surgery and RF ablation. SR prevalence was good at 74, 64 and 64% at 6, 12 and 18 months, respectively. They showed that restoring SR was associated with improving heart failure. Freedom from congestive heart failure (CHF) was 94% in SR patients compared with 69% for AF patients (P = 0.018). The New York Heart Association class was also ameliorated for those in SR compared with AF at 6 months (1.4 vs 2.7) and 18 months (1.2 vs 1.9, P < 0.0001).
Martìn-Suàrez et al. [8] retrospectively compared Cobra endocardial and epicardial monopolar RF ablation with bipolar ablation. The overall incidence of SR at the end of follow-up was higher using endocardial monopolar ablation or the bipolar RF ablation compared with the epicardial monopolar ablation (P = 0.01). The overall freedom from AF was significantly higher using bipolar ablation than either monopolar endocardial or epicardial ablation (P = 0.01).
Gillinov et al. [10] employed Atricure (West Chester, OH, USA) bipolar RF ablation in patients with permanent, persistent and paroxysmal AF undergoing concomitant cardiac surgery. AF recurrence was assessed using electrocardiogram follow-up at 1, 3, 6 and 12 months. The prevalence of AF peaked at 38% 2 weeks postoperatively. By 6 months, the prevalence decreased to 13% before increasing to 16% at 1 year. Comparatively, Geidel et al. [9] used either Cobra monopolar or Atricure bipolar RF ablation solely on patients with permanent AF and employed a longer follow-up but had similar results. At 3 and 30 months, the SR conversion rate was 73 and 77%, respectively. The survival rate was 96% at 30 months. Both ablation and total procedure times were shorter with bipolar compared with monopolar ablation. The authors strongly recommend bipolar RF due to the shorter procedure time, ability to avoid performing a standard left atriotomy and a greater guarantee of transmurality.
Three papers [6, 9, 10] utilized logistic regression analysis to demonstrate that permanent AF (P < 0.0001), a longer preoperative AF duration (P = 0.005) and larger preoperative left atrial size (P = 0.018) are predictive of postoperative AF recurrence.
Tekumit et al. [11] found SR conversion rates of 75, 78 and 79% at 3, 6 and 12 months, respectively. They concluded that LA bipolar RFA did not add significantly to the cardiopulmonary bypass time and one had no major complications from the procedure itself. They further suggested that a partial lesion as opposed to the traditional Cox-maze III complete lesion could still be effective in treating AF. Benussi et al. [12] further found that performing the mitral line with bipolar RFA is safe and cost effective. They compared their bipolar only RFA group with a control group that had the mitral line carried out using unipolar RFA. There was no significant difference in the SR recovery rate but there was a major cost difference ( per patient cost of ablation devices was €2403 in the control group vs €1245 in the study group; P < 0.0001).
Lin et al. [13] conducted a prospective trial in which patients were randomized to either undergo MW (n = 94) or RF (n = 93) ablation. At all follow-up time points ranging from discharge to 24 months, there was a significant difference in the numbers of patients remaining in SR, which favoured RF over MW ablation. The authors stated that the uncertainty in transmurality and the continuity of the lesions might have contributed to the inferior success rates of MW relative to RF ablation.
CLINICAL BOTTOM LINE
Bipolar RFA has a higher success rate in restoring SR as an adjunct to cardiac surgery compared with no ablation for at least 1 year. On average, this requires 15 min of additional cross-clamp time. The procedure had a high survival rate. While one prospective trial has provided evidence of an advantage of using bipolar RFA over MW, there is limited evidence to suggest the superiority of bipolar over unipolar RFA. In the UK, NICE guidelines have concluded that RF ablation is 'safe enough and works well enough for use in the NHS' Repeat thoractomy (19) Low cardiac output requiring an intra-aortic balloon pump (7) Sternal wound infection (2) Pneumothorax (2) Endocarditis (1) Stroke (1) GI bleed (1) Implantation of dual chamber pacemakers (4) None of the studies were completely randomized. Anti-arrhythmic drugs were not used in the three 3 months preceding surgery and for seven 7 days postoperatively
The ablation was done using RFMC with a standard bayonet bipolar forceps by holding the tissue in the jaws of the forceps and applying current
Cryoablation was applied at the AV junction and coronary sinus for LAM and BAM
The manuscript did not state the manufacturer for the device used to create the ablation set. SR patients: 94 ± 6% AF patients: 69 ± 13% P = 0.018 SR patients: 94 ± 6% AF patients: 37 ± 14% P = 0.0001 SR (1.4 ± 0.6) AF (2.7 ± 0.9) SR (1.2 ± 0.5) AF (1.9 ± 0.7) P < 0.0001
The main focus of the study was traditionally poor candidates-heart failure patients who had AF and were undergoing mitral surgery
The study is limited by small sample sizes;, however, the results demonstrate a significant improvement in the NYHA class and rehospitalization rates if patients maintain SR
Although the ablation may not be solely responsible for the improvement, it highlights the importance of restoring SR in these patients Prospective study (level 2a) There was no significant difference between bipolar RFA alone and control groups with regards to intraand postoperative clinical variables Cost per patient of the ablation devices was nearly doubled: €2403 ± 17 in the control group versusvs €1245 ± 50 (P < 0.0001) No significant difference was found in the SR recovery rate between the two study groups indicating that bipolar RFA can be used effectively for the whole procedure The authors concluded that bipolar RFA radio-frequency ablation is superior to microwave MW ablation for the treatment of permanent AF in patients undergoing valve surgery The freedom from AF recurrence was significantly higher in the radio-frequency RF group than in the MW microwave group at all time points
The authors state that the continuity and transmurality of lesions is are essential to ablation success and that transmurality in particular is harder to ensure with MW ablation AF: atrial fibrillation; AV: atrioventricular; BAM: biatrial maze; CABG: coronary artery bypass graft; CC: cross-clamp; CHF: congestive heart failure; CI: confidence interval; CL: confidence limit; CPB: cardiopulmonary bypass; DC: direct current; ECG: electrocardiogram; GI: gastrointestinal; ICU: intensive care unit; JR: junctional rhythm; LAD: left atrial diameter; LAM: left atrial maze; MW: microwave; NM: no maze; NS: non-significant; NYHA: New York Heart Association; PVIM: pulmonary vein isolation maze; RCT: randomized controlled trial; RFA: radiofrequency ablation; RFMC: radiofrequency micro bipolar coagulation; SR: sinus rhythm. Structural heart disease is very often accompanied by atrial fibrillation (AF) and can worsen the patient's condition perioperatively by haemodynamic inadequacy and low cardiac output. Since its introduction in 1987 by James Cox, the surgical maze procedure became a "gold standard" in terms of restoration of sinus rhythm. Efforts to reduce surgical risk brought about new approaches to the problem with the use of different types of energy to perform transmural and linear lesions in the atria. Bipolar radiofrequency ablation is most effective in this respect according to data in the literature [1] . Within the period May 2010 to May 2012, 63 patients with concomitant heart pathology underwent bipolar radiofrequency ablation using the AtriCure system (West Chester, OH, USA) due to persistent or long-standing persistent AF. Besides AF, other pathologies were treated: three left atrial myxomas, 12 mitral valve annuloplasties, 41 mitral valve replacements, and seven aortic valve replacements. In all 63 cases, the maze IV procedure was performed without significant influence on intervention and cross-clamping times (mean time of additional surgical ablation was 18 ± 3 minutes). During the acute period after surgery, no major surgical complications were observed. Two patients (3%) required dual-chamber pacemaker implantation because of sick sinus syndrome. All patients received amiodarone, if tolerated, or sotalol perioperatively and after discharge as the main anti-arrhythmic drug. The postablative atrial tachycardia (PAAT) rate was assessed using repetitive 4-hour Holter monitoring at 3 (after blanking period), 6, 12, 18 and 24 months respectively. Paroxysm was considered significant if lasting more than 30 seconds. At 2-year follow up, most recurrences of PAAT were observed from 6 to 12 months after surgery (14-16%); from 12 to 24 months we observed a 12% recurrence rate. Basi et al. [1] include a strong statement arising from their meta-analysis that bipolar RFA is highly successful in restoring sinus rhythm and, as a result, improving heart failure [2] . There is also clear evidence that additional surgical ablation does not significantly affect postoperative morbidity and mortality and has an advantage in terms of transmurality and cost-effectiveness versus unipolar ablation and other sources of energy [3] . According to our data, bipolar RFA has a short learning curve, is simple to use in the operating theatre and is effective. It can be used in any case of concomitant heart surgery. In some cases, such as isolated AF refractory to antiarrhythmic drugs and multiple percutaneous attempts, bipolar RFA can also be recommended to patients through thoracotomy or thoracoscopy.
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